Multi-mOdal Training Program to Promote Physical actIVity After sTrokE: MOTIVATE

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to learn if a behavioral change intervention can improve physical activity in stroke survivors living in the community. The main question it aims to answer is, if a behaviour change intervention and personalised physical activity prescription, are effective in improving the time spent in moderate to vigorous physical activity amongst chronic stroke survivors. Researchers will compare the intervention group to a control group, to see if physical activity counselling and a personalized physical activity prescription is more effective in improving moderate to vigorous physical activity, than usual care alone. The study period for each participant is 6 months. Assessments are conducted at month 1 (baseline), 3 and 6. The control group will receive only usual care, which consists of an information sheet on physical activity with the following content: (1) Why be active and (2) How to be active (with URL links to resources and videos). The usual care is delivered at 3-time points during month 1, 3 and 6. The intervention group will receive usual care and a behavioral change intervention. The behavioral change intervention consists of up to 6 individual physical activity counselling sessions and a personalized physical activity prescription. The 6 sessions will take place only during months 1 to 3 and there will be no intervention during months 4 to 6. Of the 6 sessions, 3 are conducted face-to-face and another 3 sessions will take place using telehealth methods such as phone, text messaging and videoconference. Participants can meet the study physiotherapist at their preferred exercise space during the 3 face-to-face sessions. The physical activity counselling sessions consist of goal setting and action planning, and problem-solving barriers around participation in physical activity. The overall aim is to increase time spent in moderate-vigorous physical activity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 90
Healthy Volunteers: f
View:

• Aged 21 years and over

• Haemorrhagic or ischaemic stroke

• At least 6 months post-stroke

• Living at home

• Able to walk independently +/- gait aid short distances (self-reported)

• Have sufficient cognition and/or carer support to engage in the interventions (clinical judgement)

• Agreement to undertake a supported self-management physical activity intervention programme

Locations
Other Locations
Singapore
Singapore General Hospital
RECRUITING
Singapore
Contact Information
Primary
Juliana Wang, MSc
juliana.wang.y.y@sgh.com.sg
+6597124823
Backup
Shamala Thilarajah, PhD
shamala.thilarajah@sgh.com.sg
+6591160364
Time Frame
Start Date: 2024-06-11
Estimated Completion Date: 2026-03-31
Participants
Target number of participants: 120
Treatments
Experimental: Intervention group
Study period: 6 months (1st 3 months intervention, last 3 months no intervention) No. of sessions: up to 6 per participant Mode: 3 sessions are conducted face-to-face and 3 sessions via telehealth methods e.g. phone, text message or video conferencing using virtual platforms like zoom.~Where: Face-to-face at the participant's preferred exercise space like home, outdoor fitness zone, parks, gyms etc.~Duration of sessions: each face-to-face session will take 60-90 mins Details of intervention: Physical activity counselling on adaptation of exercises, goal setting, action planning, problem solving around barriers to physical activity and provision of study resources
Active_comparator: Control group
Study period: 6 months No. of sessions: 2 sessions (at month 1 and 3) Mode: Face-to-face Where: At the participant's home Duration of session: 20- 30 minutes Details of control: physical activity information without any other support.
Related Therapeutic Areas
Sponsors
Leads: Singapore General Hospital
Collaborators: National Neuroscience Institute, Singapore Institute of Technology

This content was sourced from clinicaltrials.gov